Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
March 16 2021 - 6:22AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE
13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of March 2021
Commission File Number: 001-38396
BIOFRONTERA
AG
(Registrant’s
name / Translation of registrant’s name into English)
Hemmelrather
Weg 201, D-51377 Leverkusen Germany
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F [X] Form:40-F [ ]
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A
EXHIBITS
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
BIOFRONTERA
AG
|
|
|
|
|
|
|
By:
|
/s/
Hermann Lübbert
|
|
|
Name:
|
Hermann
Lübbert
|
|
|
Title:
|
Chief
Executive Officer
|
Date:
March 16, 2021
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Apr 2023 to Apr 2024
